In This Article:
The German market, like many global indices, has faced recent declines amid concerns over economic growth and fluctuating industrial output. Despite these challenges, the resilience of small-cap stocks with robust financial metrics offers a promising avenue for investors seeking stability and potential growth. In this article, we explore three such hidden gems in Germany's small-cap sector, starting with FRoSTA.
Top 10 Undiscovered Gems With Strong Fundamentals In Germany
Name | Debt To Equity | Revenue Growth | Earnings Growth | Health Rating |
---|---|---|---|---|
Mineralbrunnen überkingen-Teinach GmbH KGaA | 19.44% | -1.40% | -8.94% | ★★★★★★ |
Westag | NA | -1.56% | -21.68% | ★★★★★★ |
EnviTec Biogas | 37.96% | 19.34% | 51.22% | ★★★★★★ |
FRoSTA | 8.18% | 4.36% | 16.00% | ★★★★★★ |
Südwestdeutsche Salzwerke | 0.30% | 4.57% | 25.01% | ★★★★★☆ |
HOMAG Group | NA | -31.14% | 23.43% | ★★★★★☆ |
Baader Bank | 91.28% | 12.42% | -8.00% | ★★★★★☆ |
BAVARIA Industries Group | 3.19% | 0.18% | 28.18% | ★★★★★☆ |
Wilson | 64.79% | 30.09% | 68.29% | ★★★★☆☆ |
BAUER | 78.29% | 2.30% | -38.28% | ★★★★☆☆ |
Let's review some notable picks from our screened stocks.
FRoSTA
Simply Wall St Value Rating: ★★★★★★
Overview: FRoSTA Aktiengesellschaft, along with its subsidiaries, develops, produces, and markets frozen food products across Germany, Poland, Austria, Italy, and Eastern Europe with a market cap of €412.16 million.
Operations: FRoSTA generates revenue primarily from the sale of frozen food products across multiple European countries. The company has a market cap of €412.16 million.
FRoSTA, a small cap in Germany's food industry, has shown consistent earnings growth of 16% annually over the past five years. The company reported half-year sales of €315.94M and net income of €15.5M for June 2024, both stable compared to last year. With a debt-to-equity ratio reduced from 31.6% to 8.2%, FRoSTA's financial health is solid, and its P/E ratio of 12.2x remains attractive against the German market's average of 16.5x.
-
Delve into the full analysis health report here for a deeper understanding of FRoSTA.
-
Gain insights into FRoSTA's historical performance by reviewing our past performance report.
M1 Kliniken
Simply Wall St Value Rating: ★★★★★☆
Overview: M1 Kliniken AG, with a market cap of €302.20 million, provides aesthetic medicine and plastic surgery services across Germany, Austria, the Netherlands, Switzerland, the United Kingdom, Croatia, Hungary, Bulgaria, Romania, and Australia.
Operations: M1 Kliniken AG generates revenue primarily through its Trade segment (€245.49 million) and Beauty segment (€70.83 million). The company has a market cap of €302.20 million.